Logo

VolitionRx

In Brief This Week: Co-Diagnostics, Oxford Nanopore, Prenetics, Dante Labs, Seegene, More

News items for the week of May 8, 2022. 

VolitionRx Signs on Sage Healthcare as Distributor for Canine Cancer Test in Asia

The Nu.Q Vet Cancer Test is an ELISA-based blood test that identifies and measures circulating nucleosomes, an early cancer marker.

In Brief This Week: Biocept, SeqLL, Castle Biosciences, VolitionRx, More

News items for the week of March 28, 2022.

VolitionRx Awarded Additional $4 Million in Funding

The company said that part of the funding was an unsecured loan to support the analysis of tumor DNA using a nucleosome immunoprecipitation method.

VolitionRx, 4D Lifetec Partner to Combine Early Cancer Detection Assays

The companies said Tuesday that they are pursuing a clinical trial utilizing their respective liquid biopsy assays on clinical samples from lung cancer patients.

Jul 2, 2018

VolitionRx Receives $700K in Funding From Regional Government

May 9, 2018

VolitionRx, Active Motif Sign Global Sales, Distribution Agreement

Jan 3, 2017

VolitionRx Gets CE Mark for Colorectal Cancer Screening Test

Jun 3, 2016

VolitionRx Readying Launch of First Cancer Test Panel Using Circulating Nucelosome Technology
Premium

May 12, 2016

VolitionRx Launches Clinical Trial in Germany for Pancreatic Cancer Blood Test

Apr 7, 2016

VolitionRx Receives CE Marking for Two Colorectal Cancer Dx Assays

Sep 22, 2015

VolitionRx Receives CE Mark for Colorectal Cancer Diagnosis Assay

Mar 5, 2015

VolitionRx, ImmuneHealth Collaborate on Prostate Cancer Study

Feb 24, 2015

VolitionRx Acquires Nucleosome Analysis IP from Chroma Therapeutics

Feb 12, 2015

VolitionRx Closes Public Offering, Raises $8.5M

Feb 6, 2015

VolitionRx Begins Trading on NYSE MKT, Prices Public Offering at $3.75 per Share

Breaking News
The Scan

Billion-Dollar Diversity Initiative

The Howard Hughes Medical Institute is now accepting applications for its new $1.5 billion initiative to boost the diversity of the scientific workforce.

Biotech Co-Founder Arrested

A co-founder of a Los Angeles-based biotech company has been arrested in connection with a murder-for-hire scheme, according to Endpoint News.

Return of the Tasmanian Tiger

The Washington Post reports that a team in Australia is working to bring the thylacine back from extinction.

Nature Papers on Genome of Individual From Pompeii, CircRNA Study Best Practices, More

In Nature this week: first sequenced genome of a person from Pompeii, best practice guidelines for circRNA studies, and more.